I. Ketikoglou

Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study

George Papatheodoridis, Spilios Manolakopoulos, Giota Touloumi et al. · Gut · 2011 · 186 citations

Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates

A. Katsoulidou, Vana Sypsa, N.C. Tassopoulos et al. · Journal of Viral Hepatitis · 2005 · 92 citations

Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B.

I. Ketikoglou, Stelios Karatapanis, Ioannis Elefsiniotis et al. · PubMed · 2005 · 59 citations

Rheumatology, Hepatology, Autoimmune Disease +14

Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection

Vana Sypsa, Giota Touloumi, N. Tassopoulos et al. · Journal of Viral Hepatitis · 2004 · 52 citations

Hepatocellular carcinoma risk in <scp>HB</scp>eAg‐negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort

George Papatheodoridis, Spilios Manolakopoulos, Giota Touloumi et al. · Journal of Viral Hepatitis · 2014 · 45 citations · Full text